Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rangering i aksjer #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Aksjekurs
$419.17
Markedsverdi
$333.66B
Endring (1 dag)
0.50%
Endring (1 år)
14.13%
Land
CH
Handel Roche Holding AG (ROG)

Kategori

EPS for Roche Holding AG (ROG)
EPS per December 2025 TTM: $20.39
Ifølge de siste økonomiske rapportene og aksjekursen til Roche Holding AG er selskapets nåværende EPS (TTM) $20.39. Ved slutten av 2024 hadde selskapet en EPS på $11.47, en nedgang sammenlignet med EPS-en i 2023 som var $17.11.
EPS-historikk for Roche Holding AG fra 2000 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $20.39 0.00%
2025 $20.39 77.78%
2024 $11.47 -32.97%
2023 $17.11 1.86%
2022 $16.80 -6.56%
2021 $17.98 -3.42%
2020 $18.61 14.18%
2019 $16.30 30.38%
2018 $12.50 20.42%
2017 $10.38 -5.98%
2016 $11.04 6.04%
2015 $10.41 -5.87%
2014 $11.06 -25.04%
2013 $14.76 21.48%
2012 $12.15 3.66%
2011 $11.72 8.02%
2010 $10.85 23.61%
2009 $8.78 -10.11%
2008 $9.77 -2.85%
2007 $10.05 32.62%
2006 $7.58 42.29%
2005 $5.33 -22.96%
2004 $6.91 133.67%
2003 $2.96 -185.26%
2002 $-3.47 -231.20%
2001 $2.64 -58.22%
2000 $6.33 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land